Serotonin Receptor Agonists
"Serotonin Receptor Agonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS.
| Descriptor ID |
D017366
|
| MeSH Number(s) |
D27.505.519.625.850.800 D27.505.696.577.850.800
|
| Concept/Terms |
Serotonin Receptor Agonists- Serotonin Receptor Agonists
- Agonists, Serotonin Receptor
- 5-HT Agonists
- 5 HT Agonists
- Agonists, 5-HT
- 5-Hydroxytryptamine Agonists
- 5 Hydroxytryptamine Agonists
- Agonists, 5-Hydroxytryptamine
- 5-Hydroxytrytamine Agonist
- 5 Hydroxytrytamine Agonist
- Agonist, 5-Hydroxytrytamine
- Receptor Agonists, Serotonin
- Serotonergic Agonists
- Agonists, Serotonergic
- Serotonin Agonist
- Agonist, Serotonin
- Serotonin Agonists
- Agonists, Serotonin
- Serotonin Receptor Agonist
- Agonist, Serotonin Receptor
- Receptor Agonist, Serotonin
- 5-HT Agonist
- 5 HT Agonist
- Agonist, 5-HT
- Serotonergic Agonist
- Agonist, Serotonergic
|
Below are MeSH descriptors whose meaning is more general than "Serotonin Receptor Agonists".
Below are MeSH descriptors whose meaning is more specific than "Serotonin Receptor Agonists".
This graph shows the total number of publications written about "Serotonin Receptor Agonists" by people in this website by year, and whether "Serotonin Receptor Agonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 2 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Serotonin Receptor Agonists" by people in Profiles.
-
Lavoie B, Lian JB, Mawe GM. Regulation of Bone Metabolism by Serotonin. Adv Exp Med Biol. 2017; 1033:35-46.
-
Mansour NM, Ghaith O, El-Halabi M, Sharara AI. A prospective randomized trial of mosapride vs. placebo in constipation-predominant irritable bowel syndrome. Am J Gastroenterol. 2012 May; 107(5):792-3.
-
Petrakis IL, Ralevski E, Desai N, Trevisan L, Gueorguieva R, Rounsaville B, Krystal JH. Noradrenergic vs serotonergic antidepressant with or without naltrexone for veterans with PTSD and comorbid alcohol dependence. Neuropsychopharmacology. 2012 Mar; 37(4):996-1004.
-
Vanhoose AM, Ritchie MD, Winder DG. Regulation of cAMP levels in area CA1 of hippocampus by Gi/o-coupled receptors is stimulus dependent in mice. Neurosci Lett. 2004 Nov 03; 370(1):80-3.
-
Hesketh PJ. Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress. Oncology (Williston Park). 2004 Sep; 18(10 Suppl 6):9-14.
-
King JA, Tenney J, Rossi V, Colamussi L, Burdick S. Neural substrates underlying impulsivity. Ann N Y Acad Sci. 2003 Dec; 1008:160-9.
-
Chambers JJ, Parrish JC, Jensen NH, Kurrasch-Orbaugh DM, Marona-Lewicka D, Nichols DE. Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands. J Med Chem. 2003 Jul 31; 46(16):3526-35.
-
Aurigemma GP, Ronen A, Cu?noud H, Folland ED, Meyer TE. Severe mitral valve regurgitation associated with dexfenfluramine use. Cardiology. 2002; 98(4):215-7.
-
Connelly NR, Parker RK, Rahimi A, Gibson CS. Sumatriptan in patients with postdural puncture headache. Headache. 2000 Apr; 40(4):316-9.
-
Johnson MD. Electrophysiological and histochemical properties of postnatal rat serotonergic neurons in dissociated cell culture. Neuroscience. 1994 Dec; 63(3):775-87.